198 related articles for article (PubMed ID: 24455635)
1. Elizabethkingia meningoseptica bacteremia in immunocompromised hosts: The first case series from India.
Ghafur A; Vidyalakshmi PR; Priyadarshini K; Easow JM; Raj R; Raja T
South Asian J Cancer; 2013 Oct; 2(4):211-5. PubMed ID: 24455635
[TBL] [Abstract][Full Text] [Related]
2. Clinical and microbiological analysis of Elizabethkingia meningoseptica bacteremia in adult patients in Taiwan.
Lin YT; Chiu CH; Chan YJ; Lin ML; Yu KW; Wang FD; Liu CY
Scand J Infect Dis; 2009; 41(9):628-34. PubMed ID: 19579148
[TBL] [Abstract][Full Text] [Related]
3. Intrinsically Resistant Bacteria as Looming Disaster: A Rare Case Report of
Patro P; Das P; Padhi P
J Lab Physicians; 2021 Mar; 13(1):70-73. PubMed ID: 34054240
[No Abstract] [Full Text] [Related]
4. Clinical features and outcomes of critically ill patients with Elizabethkingia meningoseptica: an emerging pathogen.
Umair A; Nasir N
Acute Crit Care; 2021 Aug; 36(3):256-261. PubMed ID: 34311517
[TBL] [Abstract][Full Text] [Related]
5. A Rare Case of Elizabethkingia meningoseptica Bacteremia After Liver Transplantation.
Hoa LTV; Dang Hai P
Am J Case Rep; 2021 Nov; 22():e933992. PubMed ID: 34799546
[TBL] [Abstract][Full Text] [Related]
6. Comparison of clinical characteristics of bacteremia from Elizabethkingia meningoseptica and other carbapenem-resistant, non-fermenting Gram-negative bacilli at a tertiary medical center.
Huang YC; Wu PF; Lin YT; Wang FD
J Microbiol Immunol Infect; 2019 Apr; 52(2):304-311. PubMed ID: 30097388
[TBL] [Abstract][Full Text] [Related]
7. Comparison of the therapeutic efficacy of fluoroquinolone and non-fluoroquinolone treatment in patients with Elizabethkingia meningoseptica bacteraemia.
Huang YC; Lin YT; Wang FD
Int J Antimicrob Agents; 2018 Jan; 51(1):47-51. PubMed ID: 28668676
[TBL] [Abstract][Full Text] [Related]
8. Elizabethkingia meningoseptica Bacteremia and Meningitis: A Case Report.
Waleed MS; Amba V; Varughese AA; Pathalapati R
Cureus; 2021 Nov; 13(11):e19275. PubMed ID: 34881128
[No Abstract] [Full Text] [Related]
9.
Aldoghaim FS; Kaabia N; Alyami AM; Alqasim MA; Ahmed MA; Al Aidaroos A; Al Odayani A
New Microbes New Infect; 2019 Nov; 32():100617. PubMed ID: 31763048
[TBL] [Abstract][Full Text] [Related]
10. Role of vancomycin in the treatment of bacteraemia and meningitis caused by Elizabethkingia meningoseptica.
Jean SS; Hsieh TC; Ning YZ; Hsueh PR
Int J Antimicrob Agents; 2017 Oct; 50(4):507-511. PubMed ID: 28705672
[TBL] [Abstract][Full Text] [Related]
11. Elizabethkingia meningoseptica: an important emerging pathogen causing healthcare-associated infections.
Jean SS; Lee WS; Chen FL; Ou TY; Hsueh PR
J Hosp Infect; 2014 Apr; 86(4):244-9. PubMed ID: 24680187
[TBL] [Abstract][Full Text] [Related]
12. Risk factors and outcome of levofloxacin-resistant Elizabethkingia meningoseptica bacteraemia in adult patients in Taiwan.
Huang YC; Huang YW; Lin YT; Wang FD; Chan YJ; Yang TC
Eur J Clin Microbiol Infect Dis; 2017 Aug; 36(8):1373-1380. PubMed ID: 28265817
[TBL] [Abstract][Full Text] [Related]
13. Multidrug resistant Elizabethkingia meningoseptica bacteremia - Experience from a level 1 trauma centre in India.
Govindaswamy A; Bajpai V; Trikha V; Mittal S; Malhotra R; Mathur P
Intractable Rare Dis Res; 2018 Aug; 7(3):172-176. PubMed ID: 30181936
[No Abstract] [Full Text] [Related]
14. Clinical features, antimicrobial susceptibilities, and outcomes of Elizabethkingia meningoseptica (Chryseobacterium meningosepticum) bacteremia at a medical center in Taiwan, 1999-2006.
Hsu MS; Liao CH; Huang YT; Liu CY; Yang CJ; Kao KL; Hsueh PR
Eur J Clin Microbiol Infect Dis; 2011 Oct; 30(10):1271-8. PubMed ID: 21461847
[TBL] [Abstract][Full Text] [Related]
15. [Elizabethkingia meningosepticum bacteremia in a patient with Bardet-Biedl syndrome and chronic renal failure].
Bayrak B; Fıncanci M; Bınay UD; Çımen C; Özkantar Ünlügüneş GU
Mikrobiyol Bul; 2014 Jul; 48(3):495-500. PubMed ID: 25052117
[TBL] [Abstract][Full Text] [Related]
16. Comparison of Clinical Manifestations, Antimicrobial Susceptibility Patterns, and Mutations of Fluoroquinolone Target Genes between Elizabethkingia meningoseptica and Elizabethkingia anophelis Isolated in Taiwan.
Lin JN; Lai CH; Yang CH; Huang YH
J Clin Med; 2018 Dec; 7(12):. PubMed ID: 30545016
[No Abstract] [Full Text] [Related]
17. Epidemiological, clinical, and laboratory features of patients infected with
Li Y; Liu T; Shi C; Wang B; Li T; Huang Y; Xu Y; Tang L
Front Public Health; 2022; 10():964046. PubMed ID: 36225778
[TBL] [Abstract][Full Text] [Related]
18. Bacteremia due to Elizabethkingia meningoseptica.
Shinha T; Ahuja R
IDCases; 2015; 2(1):13-5. PubMed ID: 26793448
[TBL] [Abstract][Full Text] [Related]
19.
Ganesan V; Sundaramurthy R
Indian J Crit Care Med; 2022 Aug; 26(8):958-960. PubMed ID: 36042757
[TBL] [Abstract][Full Text] [Related]
20. Persistent
Malik W; McLeod G
IDCases; 2019; 18():e00617. PubMed ID: 31453105
[No Abstract] [Full Text] [Related]
[Next] [New Search]
